This topic contains a solution. Click here to go to the answer

Author Question: A patient with multiple sclerosis is to begin treatment with interferon beta. The patient comes to ... (Read 32 times)

armygirl

  • Hero Member
  • *****
  • Posts: 556
A patient with multiple sclerosis is to begin treatment with interferon beta. The patient comes to the clinic to have pretreatment laboratory tests. Which statement by the patient indicates a need for further teaching about these tests?
 
  a. After the first year of treatment, I will need once yearly blood work.
  b. I will need to have lab tests done every 3 months for the first year.
  c. If my liver function tests are abnormal, I will need to stop using this drug.
  d. These lab tests will measure liver and bone marrow function.

Question 2

A patient administers interferon beta-1a SQ (Rebif) 22 mcg/0.5 mL three times each week.
 
  The patient calls the nurse to report unrelieved itching and erythema at the injection site, despite the use of topical hydrocortisone for several weeks. What will the nurse tell this patient to do?
  a. Apply ice to the injection site before and after the injection.
  b. Ask the provider to reduce the dose of interferon beta to 8.8 mcg/0.2 mL.
  c. Discuss using a prescription-strength hydrocortisone product with the provider.
  d. Take oral diphenhydramine (Benadryl).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bassamabas

  • Sr. Member
  • ****
  • Posts: 294
Answer to Question 1

ANS: A
Patients treated with interferon beta require evaluation of bone marrow function with CBCs and of liver function with liver function tests (LFTs) at the beginning of therapy for baseline, every 3 months for a year, and then every 6 months thereafter. Abnormal LFTs warrant discontinuation of the drug.

Answer to Question 2

ANS: D
Oral diphenhydramine can help reduce itching and erythema. Ice is used to control pain and should be used before the injection; warm, moist compresses are used after the injection. Reducing the dose of interferon will not reduce the local reaction. Continuous use of topical steroids is not recommended because of the risk of skin damage.




armygirl

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


raenoj

  • Member
  • Posts: 340
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library